SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Adverum Biotechnologies, Inc. – ‘8-K’ for 6/23/20 – ‘EX-101.SCH’

On:  Monday, 6/29/20, at 6:45pm ET   ·   For:  6/23/20   ·   Accession #:  1193125-20-182655   ·   File #:  1-36579   ·   Correction:  This Filing’s Metadata was Corrected ® by the SEC on 7/8/20.

Previous ‘8-K’:  ‘8-K’ on 6/15/20 for 6/11/20   ·   Next:  ‘8-K’ on / for 8/10/20   ·   Latest:  ‘8-K’ on / for 3/20/24   ·   25 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/29/20  Adverum Biotechnologies, Inc.     8-K®:5,9    6/23/20   11:369K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     39K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML    133K 
 7: R1          Document and Entity Information                     HTML     49K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 6: XML         XBRL Instance -- d917807d8k_htm                      XML     14K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- advm-20200623_lab                     XML     55K 
 5: EX-101.PRE  XBRL Presentations -- advm-20200623_pre              XML     35K 
 3: EX-101.SCH  XBRL Schema -- advm-20200623                         XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
11: ZIP         XBRL Zipped Folder -- 0001193125-20-182655-xbrl      Zip     34K 


‘EX-101.SCH’   —   XBRL Schema — advm-20200623


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-4 Build:20200505.2 -->
<!-- Creation date: 6/30/2020 2:29:19 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:advm="http://www.adverum.com/20200623" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.adverum.com/20200623" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
<xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31"/>
<xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric"/>
<xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric"/>
<xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31"/>
<xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31"/>
<xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="advm-20200623_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="advm-20200623_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple"/>
<link:roleType roleURI="http://www.adverum.com//20200623/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
<link:definition> 100000 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
</xsd:schema>


25 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/21/24  Adverum Biotechnologies, Inc.     S-3                    6:637K                                   Donnelley … Solutions/FA
 3/18/24  Adverum Biotechnologies, Inc.     10-K       12/31/23   74:12M                                    Workiva Inc Wde… FA01/FA
 3/18/24  Adverum Biotechnologies, Inc.     S-8         3/18/24    4:84K                                    Donnelley … Solutions/FA
 3/04/24  Adverum Biotechnologies, Inc.     S-3                    4:276K                                   Donnelley … Solutions/FA
11/09/23  Adverum Biotechnologies, Inc.     10-Q        9/30/23   46:3.9M                                   Workiva Inc Wde… FA01/FA
 8/10/23  Adverum Biotechnologies, Inc.     10-Q        6/30/23   50:4.1M                                   Workiva Inc Wde… FA01/FA
 5/11/23  Adverum Biotechnologies, Inc.     10-Q        3/31/23   47:3.8M                                   Workiva Inc Wde… FA01/FA
 3/30/23  Adverum Biotechnologies, Inc.     10-K       12/31/22   73:8.2M                                   Workiva Inc Wde… FA01/FA
 3/30/23  Adverum Biotechnologies, Inc.     S-8         3/30/23    4:80K                                    Donnelley … Solutions/FA
11/10/22  Adverum Biotechnologies, Inc.     10-Q        9/30/22   48:4.2M                                   Workiva Inc Wde… FA01/FA
 8/11/22  Adverum Biotechnologies, Inc.     10-Q        6/30/22   50:4.2M                                   Workiva Inc Wde… FA01/FA
 8/11/22  Adverum Biotechnologies, Inc.     S-8         8/11/22    4:81K                                    Donnelley … Solutions/FA
 5/12/22  Adverum Biotechnologies, Inc.     10-Q        3/31/22   42:3.5M                                   Workiva Inc Wde… FA01/FA
 3/29/22  Adverum Biotechnologies, Inc.     10-K       12/31/21   75:10M                                    Workiva Inc Wde… FA01/FA
 3/29/22  Adverum Biotechnologies, Inc.     S-8         3/29/22    4:83K                                    Donnelley … Solutions/FA
11/04/21  Adverum Biotechnologies, Inc.     10-Q        9/30/21   50:4.6M                                   Workiva Inc Wde… FA01/FA
 8/05/21  Adverum Biotechnologies, Inc.     10-Q        6/30/21   55:5.2M                                   Workiva Inc Wde… FA01/FA
 5/06/21  Adverum Biotechnologies, Inc.     10-Q        3/31/21   57:7.4M                                   Workiva Inc Wde… FA01/FA
 3/01/21  Adverum Biotechnologies, Inc.     S-8         3/01/21    4:174K                                   Donnelley … Solutions/FA
12/17/20  Adverum Biotechnologies, Inc.     424B5                  1:434K                                   Donnelley … Solutions/FA
11/05/20  Adverum Biotechnologies, Inc.     10-Q        9/30/20   44:3.7M                                   Workiva Inc Wde… FA01/FA
 8/13/20  Adverum Biotechnologies, Inc.     424B5                  1:960K                                   Donnelley … Solutions/FA
 8/12/20  Adverum Biotechnologies, Inc.     424B5       8/11/20    1:960K                                   Donnelley … Solutions/FA
 8/10/20  Adverum Biotechnologies, Inc.     10-Q        6/30/20   53:5.9M                                   Workiva Inc Wde… FA01/FA
 8/10/20  Adverum Biotechnologies, Inc.     S-8         8/10/20    3:67K                                    Donnelley … Solutions/FA
Top
Filing Submission 0001193125-20-182655   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 7, 5:43:30.3pm ET